Jul 27 – Aug 2, 2026 · 3 new studies, 2 reviews · Orthopaedic Oncology archive · All weeks
The new Orthopaedic Oncology research The Reduction sent the week of Jul 27 – Aug 2, 2026, with the week’s most recent reviews, each with a one-line summary.
Get papers like these by email, free: subscribe to The Reduction, focused on your interests, on the days you pick.
In 23 sarcoma patients, post-treatment whole-tumor ADC values were highly reproducible and strongly predicted pathologic response to neoadjuvant radiotherapy, whereas sub-regional and longitudinal ADC changes were less reliable.
In 22 patients, en-bloc thoracolumbar spondylectomy for spinal tumors achieved good oncologic control (5-year overall survival 64%) but high morbidity, with marginal margins seeming adequate while intralesional margins were linked to recurrence.
Meta-analysis suggests cement-augmented pedicle screws may lower hardware failure rates versus conventional fixation in metastatic spine surgery (4.3% vs 12.5%), but evidence certainty is low.
This AAOS-endorsed guideline offers seven evidence-based recommendations for surgical management of metastatic, myeloma, and lymphoma disease of the humerus.
Endoprosthetic Reconstruction of the Upper Extremity in Oncologic Surgery.
This review shows that despite complex regional anatomy, endoprosthetic reconstruction of the scapula and humerus yields excellent mid- to long-term pain relief and function for both oncologic and non-oncologic bone loss.
← Week of Jul 20–26, 2026Week of Aug 3–9, 2026 →
Home · All weeks · Archive · Subscribe · FAQ
© 2026 The Reduction